Anti-Rheumatic Rx
Patients with refractory gout and those with high burden of tophi have only few options when it comes to uric acid lowering agents.
Many of these patients have coexisting chronic kidney disease (CKD…
The last day was jammed with important reports and research including the late breaking abstracts.
What imaging modality is best in GCA?
Dutch study: n=42
?GCA got all three of USS, PET/CT, MRI…
1 year ago
Curtis et al. Primary non-adherence to csDMARDs and b/tsDMARDs in RA/PsA/SpA. Medicare and commerically-insured patients. 20-44%! of new prescriptions not filled by 6 months. Higher for csDMARDs than b/tsDMARDs @RheumNow #ACR22 Abstr#2199 https://t.co/Pwg6GKu7Gg https://t.co/wPF0pu1UDa
1 year ago
Which is better for CV risk in RA:
triple therapy DMARDs or TNFi?
TARGET study
n=159 using PET/CT surrogate (endpoint responsiveness👀)
- either led to benefit
- both equally good
- benefit *not* linked to change in DAS28
A direct CV effect of RA Rx?
ABST2215 #ACR22 @RheumNow https://t.co/4FPvSbfGsD
1 year ago
Bass et al. Treatment ICI-arthritis. Tricky one. MTX alone assoc longer time to cancer progression and to arthritis control compared to combination with bDMARD. Thoughts @drdavidliew ? @RheumNow #ACR22 Abstr#1669 https://t.co/8KH8RZzcaZ https://t.co/DtpA8s4PLy
1 year ago
Are your SpA pts planning on conceiving? Be careful with NSAID use
French study found age and NSAID use associated with longer time-to-conception.
Factors not associated: smoking, BASDAI score, DMARD use
#ACRBest Abs#1673 @RheumNow #ACR22 https://t.co/D63XTY7IB8
1 year ago
Hamroun et al. Preconceptual NSAID use assoc impaired fertility in SpA, HR 3.01 for time-to-conception @RheumNow #ACR22 Abstr#1673 https://t.co/jresR9MfXF https://t.co/flyfJob9un
1 year ago
Important late breaker re:barriers to MTX post Roe decision
6% of respondents who tried to fill MTX had barriers to access; most commonly related to pharmacies/pharmacists
This number should be 0%!!
#ACR22 abstr#L09 @RheumNow https://t.co/dgZkJLlL25
Poster Hall